1. Home
  2. JVA vs SNTI Comparison

JVA vs SNTI Comparison

Compare JVA & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coffee Holding Co. Inc.

JVA

Coffee Holding Co. Inc.

HOLD

Current Price

$4.12

Market Cap

21.0M

ML Signal

HOLD

Logo Senti Biosciences Inc.

SNTI

Senti Biosciences Inc.

HOLD

Current Price

$1.06

Market Cap

53.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JVA
SNTI
Founded
1971
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.0M
53.6M
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
JVA
SNTI
Price
$4.12
$1.06
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$9.00
AVG Volume (30 Days)
30.7K
4.5M
Earning Date
01-30-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
64.91
N/A
EPS
0.32
N/A
Revenue
$89,748,681.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$150.00
P/E Ratio
$11.33
N/A
Revenue Growth
17.92
N/A
52 Week Low
$2.75
$1.12
52 Week High
$9.93
$5.10

Technical Indicators

Market Signals
Indicator
JVA
SNTI
Relative Strength Index (RSI) 66.62 31.30
Support Level $3.60 $1.15
Resistance Level $3.80 $1.28
Average True Range (ATR) 0.19 0.21
MACD 0.06 -0.05
Stochastic Oscillator 92.02 0.27

Price Performance

Historical Comparison
JVA
SNTI

About JVA Coffee Holding Co. Inc.

Coffee Holding Co Inc is engaged in wholesale coffee operations, including manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees for privately labeled accounts and its brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada, and certain Asian countries. The group's services are Custom Blending, Food Service Programs, and Private Label Services.

About SNTI Senti Biosciences Inc.

Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.

Share on Social Networks: